Noom Med vs Oak Longevity: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Oak Longevity scores higher on our rubric, 7.5/10 against 7.4/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Oak Longevity - our pick of these two →or find your match

Oak Longevity beats Noom Med overall, scoring 7.5/10 vs 7.4/10. Published pricing is not a like-for-like monthly comparison: Noom Med is $79 first month, then $199/mo; Oak Longevity is from $119/mo. Choose Noom Med for users who want a low-dose glp-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing. Choose Oak Longevity for budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).

A side-by-side look at Noom Med and Oak Longevity to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Noom Med

#23 of 54

7.4/10

Noom restructured Noom Med in 2026 into a GLP-1 ladder plus a non-GLP-1 pill: Microdose GLP-1Rx at $79 then $199/mo, GLP-1Rx at $129 then $249/mo, GLP-1Rx Plus at $149 then $299/mo, and a metformin pill at $69 then $99/mo that is not a GLP-1. Verified 2026-07-27. Historic note: the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.

Visit Noom Med

Higher Rated

Oak Longevity

#21 of 54

7.5/10

Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing, patients pay each month manually rather than auto-renew.

Visit Oak Longevity

Feature	Noom Med	Oak Longevity
Why each one	The only GLP-1 platform built on a decade of behavioral psychology research, combining medication with Noom's proven coaching methodology for lasting habit change.	The no-subscription billing model, patients are not auto-charged each month and renew manually. Combined with the broadest medication mix (compounded GLP-1s + oral Wegovy + brand-name + longevity peptides), Oak occupies a unique position as a 'menu' platform vs. the typical single-product flow.
Our Score	7.4/10	7.5/10
Headline Price	$79 first month, then $199/mo	from $119/mo
Medication Type	Both	Both
Insurance Accepted	Yes	No
Best For	Users who want a low-dose GLP-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing	Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin)
Watch out for	Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27]	Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare lists Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and LillyDirect has Zepbound from $299. Use Oak for its compounded tiers and buy brand-name direct
Ranking	#23	#21
Get started	Visit Noom Med	Visit Oak Longevity

Pros & Cons Compared

Noom Med

Pros

+Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
+Microdose GLP-1Rx is $79 for the first 4 weeks then $199/mo billed quarterly, low-dose GLP-1 plus biomarker monitoring for side-effect-sensitive users [Verified 2026-07-27]
+Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
+Industry-leading behavioral coaching app with years of psychology-based weight loss methodology

Cons

−Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27]
−Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
−Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
−App coaching still requires real engagement, skip-prone users waste the behavioral value

Oak Longevity

Pros

+$119/mo for compounded semaglutide is among the lowest published entries in our provider table
+No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
+Compounded tirzepatide at $185/mo is competitively priced for a GLP-1+GIP dual agonist
+Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
+Money-back guarantee if not approved by physician, useful safety net for borderline-eligibility patients
+Free shipping and free health coaching included in every program

Cons

−Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare lists Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and LillyDirect has Zepbound from $299. Use Oak for its compounded tiers and buy brand-name direct
−No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
−The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan
−The longevity add-ons (NAD+, Sermorelin, Tesamorelin) have limited clinical evidence for weight loss specifically, if weight loss is the goal, the GLP-1 alone does the work and the stack is optional
−Newer brand without disclosed company history, founding date, or executive team on landing pages
−Three-month plans are billed upfront, start on the 1-month plan if you're testing the platform, then bundle once it fits

Our Verdict

Oak Longevity edges out Noom Med with a score of 7.5/10 vs 7.4/10. Published pricing is not a like-for-like monthly comparison: Noom Med is $79 first month, then $199/mo; Oak Longevity is from $119/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs.